In these uncertain times, many look to Franklin D. Roosevelt’s quote “The only thing we have to fear is . . . fear itself.” But what does that really mean?
The COVID-19 Pandemic and Emotional Wellbeing: Tips for Healthy Routines and Rhythms During Unpredictable Times
Recommendations from the International Society of Bipolar Disorders Task Force on Chronobiology and Chronotherapy and the Society for Light Treatment and Biologic Rhythms.
Dr Giovanni Fava shares his perspective on the current intellectual crisis in psychiatry and how it stems from a narrow concept of science which neglects clinical practice as a source of fundamental research questions.
The current COVID-19 pandemic has raised a number of issues related to the role and importance of psychiatrists compared with medical colleagues at this time of widespread illness and massive changes.
So begins this transformative journey to calm, peace, and tranquility in the face of a “coronacopia” of life upending challenges.
We often push thoughts of death far out of our awareness, but at the present time they unavoidably re-emerge. Can we learn something helpful from this?
Hearing about Coronavirus 2019 from opinionated and often unreliable sources made this 15-year-old more nervous than she needed to be.
A number of factors affect treatment adherence, including the therapeutic alliance, perceived perceived lack of control, risk of dependence on medications, stigma associated with medication use, and more.
The US Food and Drug Administration is working diligently to provide the public with information to keep consumers well and safe. From hand sanitizers to testing to food safety, this slideshow presents the latest developments.
Reports of verbal and physical aggression toward Chinese-American people have undeniable ripple effects, and if left unmonitored, turns into full-fledged Coronasiaphobia.
Is there special guidance for APA members regarding COVID-19 and their practices/patients? What resources are available?
It’s been tornados, volcanoes, epidemics, and more. Now we have COVID-19; is the coronavirus here to stay?
On Thursday, March 26, the FDA granted authorization for SomrystTM, a prescription-only digital therapeutic for treatment of chronic insomnia in patients aged 22 years or older.
Take our brief survey and become a member of the Psychiatric Times Reader Reactor Panel.
How can psychiatrists practice self-care and avoid burnout? How can mental health professionals balance the needs to protect oneself and one’s family while caring for patients during this pandemic?